Journal for ImmunoTherapy of Cancer (Aug 2021)
CXCR6 is required for antitumor efficacy of intratumoral CD8+ T cell
- Wei Huang,
- Qiang Xu,
- Yi Wang,
- Yang Sun,
- Zhigang Tian,
- Hongqi Chen,
- Xiaofan Sun,
- Binglin Wang,
- Guoliang Deng,
- Xingxin Wu,
- Yanghong Gu,
- Zhimin Fan
Affiliations
- Wei Huang
- State Key Laboratory of Pharmaceutical Biotechnology, Chemistry and Biomedicine Innovation Center (ChemBIC), School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China
- Qiang Xu
- State Key Laboratory of Pharmaceutical Biotechnology, Chemistry and Biomedicine Innovation Center (ChemBIC), School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China
- Yi Wang
- Department of Proctology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
- Yang Sun
- State Key Laboratory of Pharmaceutical Biotechnology, Chemistry and Biomedicine Innovation Center (ChemBIC), School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China
- Zhigang Tian
- School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
- Hongqi Chen
- Department of General Surgery, Shanghai Jiao Tong University Affiliated Sixth People`s Hospital, Shanghai, China
- Xiaofan Sun
- State Key Laboratory of Pharmaceutical Biotechnology, Chemistry and Biomedicine Innovation Center (ChemBIC), School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China
- Binglin Wang
- State Key Laboratory of Pharmaceutical Biotechnology, Chemistry and Biomedicine Innovation Center (ChemBIC), School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China
- Guoliang Deng
- State Key Laboratory of Pharmaceutical Biotechnology, Chemistry and Biomedicine Innovation Center (ChemBIC), School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China
- Xingxin Wu
- State Key Laboratory of Pharmaceutical Biotechnology, Chemistry and Biomedicine Innovation Center (ChemBIC), School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China
- Yanghong Gu
- Department of Oncology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China
- Zhimin Fan
- Department of Proctology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
- DOI
- https://doi.org/10.1136/jitc-2021-003100
- Journal volume & issue
-
Vol. 9,
no. 8
Abstract
No abstracts available.
